查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1938357

胃內球囊市場 - 全球產業規模、佔有率、趨勢、機會及預測（按給藥方式、球囊類型、充盈類型、應用、最終用戶、地區和競爭格局分類，2021-2031年）

Intragastric Balloons Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Administration, By Balloon Type, By Filling Type, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球胃內球囊市場預計將從 2025 年的 8,627 萬美元成長到 2031 年的 1.7885 億美元，複合年成長率為 12.92%。

這些臨時性的微創裝置透過佔據胃部空間來誘導早期飽腹感，有效彌合了保守的生活方式調整和侵入性減肥手術之間的關鍵治療缺口。這一市場成長的根本驅動力是日益嚴重的全球肥胖問題，亟需可擴展的治療方案。例如，世界肥胖聯盟在2024年預測，到2035年，全球肥胖成年人數將達到15.3億，這將持續催生對風險低於永久性手術的非手術體重管理方案的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 8627萬美元
市場規模：2031年 1.7885億美元
複合年成長率：2026-2031年 12.92%
成長最快的細分市場 生理食鹽水填充型
最大的市場 北美洲

然而，儘管市場需求明確，但器械安全性和潛在不利事件仍構成市場擴張的重大障礙。包括自發性球囊過度充氣、急性胰臟炎和胃穿孔在內的併發症報告，導致監管機構加強審查並發布安全警告，降低了患者的信心和接受度。此外，高昂的手術費用以及保險公司報銷不均或報銷額度有限等經濟障礙，進一步限制了市場准入，導致相當一部分合格的患者無法獲得這些治療。

市場促進因素

推動胃內球囊市場發展的主要因素是全球肥胖和超重人口的成長，這迫切需要有效的干涉措施來彌合生活方式改變和侵入性手術之間的差距。隨著全球體重指數（BMI）水平的上升，醫療保健系統正轉向擴充性的、基於器械的治療方法，以減輕肥胖相關併發症的負擔。近期監測數據凸顯了這項人口壓力。 KGOU 2025年12月的一份報告引述美國疾病管制與預防中心（CDC）的數據指出，到2024年，美國所有州和地區至少四分之一的成年人將患有肥胖症。這凸顯了公共衛生危機的嚴重性以及由此產生的對非手術治療方案的需求。

此外，諸如可吞嚥可調節球囊設計等技術創新，解決了患者對傳統內視鏡插入風險和侵入性的擔憂，正在推動市場成長。新一代基於平板電腦的給藥系統實現了非手術部署，提高了患者依從性，並將市場拓展至尋求可逆、低風險治療方案的患者群體。這些進步的商業性成功顯而易見：2025年6月，Allurion Technologies報告稱，其B2B2C銷售模式在歐洲實現了超過40%的成長，顯示消費者需求強勁。此外，Allurion在2025年3月宣布2024會計年度全年營收達3,210萬美元，鞏固了該行業的財務永續性，並表明這些技術的普及應用日益廣泛。

市場挑戰

全球胃內球囊市場成長的主要障礙在於人們對該器械安全性和不利事件的持續擔憂。儘管這些器械的設計理念是微創，但諸如自發性過度充氣、急性胰臟炎和胃穿孔等嚴重併發症的發生，導致監管機構加強審查、發布安全警告並強制召回產品。這些問題直接削弱了患者的信心，並導致醫療服務提供者不願意推薦這種療法。因此，對於相當一部分合格的患者而言，潛在臨床風險的擔憂超過了其預期獲益，從而導致猶豫不決和市場滲透率有限。

這些安全隱患的實際影響體現在手術量的急劇下降。美國代謝與減重外科協會 (ASMBS) 預計，2023 年美國胃內球囊手術的數量將降至 1461 例，較前一年的 4358 例大幅下降。這一顯著下降表明，安全隱患以及由此產生的臨床謹慎態度正在有效地抑制市場成長，並阻礙該技術達到能夠滿足日益成長的非手術減重治療需求的規模。

市場趨勢

人工智慧驅動的數位健康生態系統的整合正在重塑胃內球囊市場，並將產業重點轉向綜合護理模式。製造商正日益將設備與演算法指導平台結合，以追蹤即時生理指標，從而提高患者安全性和治療依從性。這個數位化層面支持個人化干預，有助於實現重要的臨床結果，例如在減重過程中保持肌肉量。 Allurion Technologies 在新聞稿中強調了這種方法的價值，該新聞稿引用了該公司在 2025 年 5 月歐洲肥胖研究學會會議上公佈的數據。該公司報告稱，使用其人工智慧虛擬護理套件的患者在四個月內平均瘦體重增加了 6.1%，證明了數位輔助性治療的有效性。

同時，一種全新的高效治療模式正在興起：胃內球囊合併GLP-1受體促效劑的聯合治療。透過利用球囊的機械飽足感，臨床醫生可以減少藥物劑量，最大限度地降低減重，並改善體重減輕效果。這種協同療法能夠最大限度地減少脂肪，並克服單一療法的局限性，例如減重停滯期。 Alurion Technologies公司於2025年11月公佈的數據支持了此策略的有效性。接受該公司智慧膠囊聯合治療低劑量替拉唑肽治療的患者，在12個月後平均體重減輕了23%，顯著優於以往僅使用器械治療的效果。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球胃內球囊市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依給藥途徑（片劑與內視鏡）
    • 依氣球類型（單層、雙層、三層）
    • 依充注類型（生理食鹽水充注與氣體充填）
    • 依用途（肥胖、糖尿病、飲食管理等）
    • 依最終使用者（醫院/診所、門診手術中心、其他）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美胃內球囊市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲胃內球囊市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區胃內球囊市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲胃內球囊市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲胃內球囊市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球胃內球囊市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Apollo Endosurgery, Inc.
  • Allurion Technologies, Inc.
  • Obalon Therapeutics, Inc.
  • Medtronic plc
  • GI Dynamics, Inc.
  • Spatz Medical, Inc.
  • Lexel Medical, Inc.
  • Bariatric Solutions, Inc.
  • Endogastric Solutions, Inc.
  • Reshape Lifesciences, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7390

The Global Intragastric Balloons Market is projected to expand from USD 86.27 Million in 2025 to USD 178.85 Million by 2031, registering a CAGR of 12.92%. These temporary, minimally invasive devices function by occupying gastric space to induce early satiety, effectively addressing the critical treatment gap between conservative lifestyle adjustments and invasive bariatric surgeries. This market growth is fundamentally driven by the escalating global burden of obesity, which demands scalable therapeutic solutions. For instance, the World Obesity Federation projected in 2024 that the number of adults living with obesity worldwide would rise to 1.53 billion by 2035, creating sustained demand for non-surgical weight management options with a more favorable risk profile than permanent surgical procedures.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 86.27 Million
Market Size 2031USD 178.85 Million
CAGR 2026-203112.92%
Fastest Growing SegmentSaline Filled
Largest MarketNorth America

However, despite the clear demand, market expansion faces significant hurdles regarding device safety and potential adverse events. Reports of complications, such as spontaneous balloon hyperinflation, acute pancreatitis, and gastric perforation, have triggered increased regulatory scrutiny and safety alerts that diminish patient confidence and adoption rates. Additionally, financial barriers further restrict market access, as high procedural costs are often compounded by inconsistent or limited reimbursement coverage from insurance payers, preventing a substantial portion of the eligible patient population from accessing these treatments.

Market Driver

The primary catalyst propelling the intragastric balloons market is the rising global prevalence of obesity and overweight populations, which necessitates effective interventions to bridge the divide between lifestyle modifications and invasive surgeries. As body mass index levels increase globally, healthcare systems are turning to scalable, device-based therapies to alleviate the burden of obesity-related comorbidities. This demographic pressure is highlighted by recent surveillance data; a December 2025 report by KGOU citing Centers for Disease Control and Prevention data revealed that in 2024, at least one in four adults across all U.S. states and territories lived with obesity, underscoring the severity of this public health crisis and the resulting demand for non-surgical therapeutic alternatives.

Market growth is further accelerated by technological innovations in swallowable and adjustable balloon designs, which address patient apprehensions regarding the risks and invasiveness of traditional endoscopic placement. Next-generation, pill-based delivery systems enable procedure-less deployment, thereby enhancing patient compliance and broadening the market to those seeking reversible, lower-risk options. The commercial success of these advancements is evident; Allurion Technologies reported in June 2025 that its B2B2C sales model achieved over 40% growth in Europe, indicating strong consumer uptake. Furthermore, the segment's financial viability was reinforced when Allurion announced a full-year 2024 revenue of $32.1 million in March 2025, demonstrating the increasing utilization of these technologies.

Market Challenge

A major impediment to the growth of the global intragastric balloons market is the persistent concern surrounding device safety and adverse events. While these devices are designed to be minimally invasive, incidents of serious complications-including spontaneous hyperinflation, acute pancreatitis, and gastric perforation-have led to intensified regulatory scrutiny, safety alerts, and mandatory product recalls. These issues directly undermine patient confidence and deter healthcare providers from recommending the therapy. Consequently, for a significant segment of eligible patients, the fear of potential clinical risks often outweighs the perceived benefits, resulting in hesitancy and limited market penetration.

The tangible impact of these safety challenges is evident in the sharp contraction of procedural volumes. According to the American Society for Metabolic and Bariatric Surgery, the estimated number of intragastric balloon procedures in the United States fell to 1,461 in 2023, a significant decline from the 4,358 procedures recorded the prior year. This substantial decrease illustrates how safety-related apprehensions and the resulting caution within clinical practice are effectively stifling market growth, preventing the technology from reaching the scale needed to meet the escalating demand for non-surgical weight loss interventions.

Market Trends

The intragastric balloons market is being reshaped by the integration of AI-driven digital health ecosystems, shifting the industry focus toward comprehensive care models. Manufacturers are increasingly pairing devices with algorithmic coaching platforms that track real-time physiological metrics to improve patient safety and adherence. This digital layer facilitates personalized interventions that support essential clinical outcomes, such as muscle preservation during weight loss. The value of this approach was highlighted by Allurion Technologies in May 2025; in a press release regarding data presented at the European Congress on Obesity, the company reported that patients using its AI-powered Virtual Care Suite achieved an average lean body mass increase of 6.1% over four months, validating the efficacy of digital adjuncts.

Concurrently, a new high-efficacy treatment paradigm is emerging through combination therapies that pair intragastric balloons with GLP-1 receptor agonists. By utilizing the balloon's mechanical satiety, clinicians can prescribe lower pharmaceutical dosages to minimize side effects while enhancing overall weight loss. This synergistic approach maximizes fat reduction and overcomes the limitations of standalone pharmacotherapy, such as weight loss plateaus. The potency of this strategy was underscored in November 2025, when Allurion Technologies released data showing that patients on a regimen of its Smart Capsule and low-dose tirzepatide achieved an average total body weight loss of 23% after 12 months, a result significantly surpassing historical outcomes for device-only interventions.

Key Market Players

  • Apollo Endosurgery, Inc.
  • Allurion Technologies, Inc.
  • Obalon Therapeutics, Inc.
  • Medtronic plc
  • GI Dynamics, Inc.
  • Spatz Medical, Inc.
  • Lexel Medical, Inc.
  • Bariatric Solutions, Inc.
  • Endogastric Solutions, Inc.
  • Reshape Lifesciences, Inc.

Report Scope

In this report, the Global Intragastric Balloons Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intragastric Balloons Market, By Administration

  • Pill Form v/s Endoscopy

Intragastric Balloons Market, By Balloon Type

  • Single
  • Dual
  • Triple

Intragastric Balloons Market, By Filling Type

  • Saline Filled v/s Gas Filled

Intragastric Balloons Market, By Application

  • Obesity
  • Diabetes
  • Diet Control
  • Others

Intragastric Balloons Market, By End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Intragastric Balloons Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intragastric Balloons Market.

Available Customizations:

Global Intragastric Balloons Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intragastric Balloons Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Administration (Pill Form v/s Endoscopy)
    • 5.2.2. By Balloon Type (Single, Dual, Triple)
    • 5.2.3. By Filling Type (Saline Filled v/s Gas Filled)
    • 5.2.4. By Application (Obesity, Diabetes, Diet Control, Others)
    • 5.2.5. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Intragastric Balloons Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Administration
    • 6.2.2. By Balloon Type
    • 6.2.3. By Filling Type
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intragastric Balloons Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Administration
        • 6.3.1.2.2. By Balloon Type
        • 6.3.1.2.3. By Filling Type
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Intragastric Balloons Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Administration
        • 6.3.2.2.2. By Balloon Type
        • 6.3.2.2.3. By Filling Type
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Intragastric Balloons Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Administration
        • 6.3.3.2.2. By Balloon Type
        • 6.3.3.2.3. By Filling Type
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Intragastric Balloons Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Administration
    • 7.2.2. By Balloon Type
    • 7.2.3. By Filling Type
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Intragastric Balloons Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Administration
        • 7.3.1.2.2. By Balloon Type
        • 7.3.1.2.3. By Filling Type
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. France Intragastric Balloons Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Administration
        • 7.3.2.2.2. By Balloon Type
        • 7.3.2.2.3. By Filling Type
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Intragastric Balloons Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Administration
        • 7.3.3.2.2. By Balloon Type
        • 7.3.3.2.3. By Filling Type
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Intragastric Balloons Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Administration
        • 7.3.4.2.2. By Balloon Type
        • 7.3.4.2.3. By Filling Type
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Intragastric Balloons Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Administration
        • 7.3.5.2.2. By Balloon Type
        • 7.3.5.2.3. By Filling Type
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia Pacific Intragastric Balloons Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Administration
    • 8.2.2. By Balloon Type
    • 8.2.3. By Filling Type
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Intragastric Balloons Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Administration
        • 8.3.1.2.2. By Balloon Type
        • 8.3.1.2.3. By Filling Type
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Intragastric Balloons Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Administration
        • 8.3.2.2.2. By Balloon Type
        • 8.3.2.2.3. By Filling Type
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Intragastric Balloons Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Administration
        • 8.3.3.2.2. By Balloon Type
        • 8.3.3.2.3. By Filling Type
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Intragastric Balloons Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Administration
        • 8.3.4.2.2. By Balloon Type
        • 8.3.4.2.3. By Filling Type
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Intragastric Balloons Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Administration
        • 8.3.5.2.2. By Balloon Type
        • 8.3.5.2.3. By Filling Type
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Middle East & Africa Intragastric Balloons Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Administration
    • 9.2.2. By Balloon Type
    • 9.2.3. By Filling Type
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Intragastric Balloons Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Administration
        • 9.3.1.2.2. By Balloon Type
        • 9.3.1.2.3. By Filling Type
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Intragastric Balloons Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Administration
        • 9.3.2.2.2. By Balloon Type
        • 9.3.2.2.3. By Filling Type
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Intragastric Balloons Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Administration
        • 9.3.3.2.2. By Balloon Type
        • 9.3.3.2.3. By Filling Type
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Intragastric Balloons Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Administration
    • 10.2.2. By Balloon Type
    • 10.2.3. By Filling Type
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Intragastric Balloons Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Administration
        • 10.3.1.2.2. By Balloon Type
        • 10.3.1.2.3. By Filling Type
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Intragastric Balloons Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Administration
        • 10.3.2.2.2. By Balloon Type
        • 10.3.2.2.3. By Filling Type
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Intragastric Balloons Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Administration
        • 10.3.3.2.2. By Balloon Type
        • 10.3.3.2.3. By Filling Type
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Intragastric Balloons Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Apollo Endosurgery, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Allurion Technologies, Inc.
  • 15.3. Obalon Therapeutics, Inc.
  • 15.4. Medtronic plc
  • 15.5. GI Dynamics, Inc.
  • 15.6. Spatz Medical, Inc.
  • 15.7. Lexel Medical, Inc.
  • 15.8. Bariatric Solutions, Inc.
  • 15.9. Endogastric Solutions, Inc.
  • 15.10. Reshape Lifesciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer